Inhibition of hypoxia inducible factor-1α (HIF-1α) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas

By Jensen Randy   Ragel Brian   Whang Kum   Gillespie David  

Journal of Neuro-Oncology, Vol. 78, Iss. 3, 2006-07 ,pp. : 233-247

Springer Publishing Company

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 59-71

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical utility of vascular endothelial growth factor in diagnosing malignant pleural effusions

By Shu Jun   Sun Gengyun   Liu Haibo   Liu Jing  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 1004-1011

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 8, 2010-10 ,pp. : 593-600

Bentham Science Publishers

Access to resources Recommend Favorite

Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors

By                      

Oncology Reports, Vol. 33, Iss. 5, 2015-01 ,pp. : 2345-2353

Spandidos Publications

Access to resources Recommend Favorite